News
BGP advises Memo Therapeutics regarding its CHF 14 Mio. Series B financing round
11. November 2020
Bader Gnehm & Partner advised Memo Therapeutics Ltd in a CHF 14 million Series B financing round, involving the investors Swisscanto Invest, BERNINA BioInvest, Redalpine, Jaquet Partners and Schroder Adveq.
Memo Therapeutics Ltd, an innovator in the field of antibody discovery and immune repertoire analysis, intends to use the proceeds to further develop its lead antibody candidate "MTX-COVAB" for the treatment of COVID-19.
Memo Therapeutics Ltd was advised in all legal matters with regard to the Series B financing round by Bader Gnehm & Partner. The team consisted of Oliver Gnehm (Partner), Denis A. Parvex (Associate) and Thomas Gysin (Associate).
Bader Gnehm & Partner has been repeatedly awarded as top law firm in the area of "Private Equity and Venture Capital".
The press release of Memo Therapeutics Ltd can be found here.
Araris Biotech raises CHF 15.2 mio in Seed financing round
06. November 2020
Araris Biotech Ltd has obtained CHF 15.2 million in a Seed financing round from the investors Pureos Bioventures, 4BIO Capital, btov Partners, Redalpine, VI Partners and Schroder Adveq.
Araris Biotech Ltd, a company pioneering antibody-drug conjugate (ADC)-linker technology, intends to use the proceeds to support advancement of lead ADCs into preclinical and clinical development.
Araris Biotech Ltd was advised in all legal matters with regard to the Seed financing round by Bader Gnehm & Partner. The team consisted of Oliver Gnehm (Partner), Denis A. Parvex (Associate) and Thomas Gysin (Associate).
Bader Gnehm & Partner has been repeatedly awarded as top law firm in the area of "Private Equity and Venture Capital".
The press release of Araris Biotech Ltd can be found here: Araris Biotech
BGP Berne is moving
12. October 2020
We are moving into new premises in the Länggasse!
As of 5 October 2020 you will find our Berne office at Länggassstrasse 10, 3012 Bern.
We kindly ask you to use our new mailing address from now on. Our phone and fax numbers as well as e-mail addresses remain unchanged.
.
Trade & Export Finance
13. July 2020
Bader Gnehm & Partner advised a Swiss exporter of disaster control equipment in the negotiation and conclusion of a complex, multi-staged sale and purchase transaction involving letter of credits, performance guarantees and several international parties, including inter alia a Swiss bank and a Chinese purchaser.
The Swiss exporter was advised in all legal matters by Bader Gnehm & Partner. The team was led by Oliver Gnehm (Partner) and furthermore included Denis A. Parvex (Associate).
Bader Gnehm & Partner’s Trade & Export Finance team features experienced specialists delivering comprehensive legal and negotiation services to market players and industries involved in international commerce, trade and export finance.
More information can be found here.
Bader Gnehm & Partner Ltd
02. June 2020
After more than 30 years as simple partnership, Bader Gnehm & Partner will be operating as a stock corporation as of June 1st, 2020.
The five founding partners Michael Bader, Oliver Gnehm, Elena Mégevand, Stefan Kunz and Olivier Bula are the new shareholders. Kathrin Straub will remain with Bader Gnehm & Partner Ltd as Of Counsel..
For the law firm, this is a further step in its modernisation. It will strengthen the cooperation across locations between the attorneys in Berne and Zurich and will place even greater emphasis on efficiency in our services.
We look forward to further exciting and successful years with our clients.